Drug Profile
V 20
Alternative Names: V20Latest Information Update: 24 Sep 2021
Price :
$50
*
At a glance
- Originator GLYCODesign
- Class Antiplatelets; Vascular disorder therapies
- Mechanism of Action Platelet aggregation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis